about
A novel assay to measure B cell responses to keyhole limpet haemocyanin vaccination in healthy volunteers and subjects with systemic lupus erythematosus.Intestinal microsporidiosis: a hidden risk in rheumatic disease patients undergoing anti-tumor necrosis factor therapy combined with disease-modifying anti-rheumatic drugs?Combination antibiotics for the treatment of Chlamydia-induced reactive arthritis: is a cure in sight?Past hepatitis B virus infection in rheumatoid arthritis patients receiving biological and/or nonbiological disease-modifying antirheumatic drugsRecurrent infections in a patient with psoriatic arthritis and hypogammaglobulinemia, treated with conventional and biologic disease-modifying anti-rheumatic drugs-a primary or secondary entity?Successful treatment of an invasive fungal infection caused by Talaromyces sp. with voriconazole
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on July 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Infectious complications of biological therapy.
@en
Infectious complications of biological therapy.
@nl
type
label
Infectious complications of biological therapy.
@en
Infectious complications of biological therapy.
@nl
prefLabel
Infectious complications of biological therapy.
@en
Infectious complications of biological therapy.
@nl
P1476
Infectious complications of biological therapy
@en
P2093
Nigil Haroon
Robert D Inman
P304
P356
10.1097/BOR.0B013E32832C792D
P577
2009-07-01T00:00:00Z